Plus, news about Bristol Myers Squibb, Nanobiotix, Biogen, bluebird bio, Kairos, BioCardia and Immuto Scientific:
🧪 Nektar Therapeutics’ full Phase 2b eczema data: The company said rezpegaldesleukin, commonly known as rezpeg ...
↧